Life Stem Genetics Inc.

OTCPK:LIFS Stock Report

Market Cap: US$245.0

Life Stem Genetics Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Gloria Simov

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure11.5yrs
CEO ownershipn/a
Management average tenure11.3yrs
Board average tenure11.1yrs

Recent management updates

No updates

Recent updates

No updates

CEO

Gloria Simov (38 yo)

11.5yrs

Tenure

US$5,000

Compensation

Ms. Gloria Simov has been Chief Executive Officer and President of Life Stem Genetics, Inc. since August 26, 2013. As well as carrying out her executive functions, Ms. Simov is responsible for development...

Leadership Team

NamePositionTenureCompensationOwnership
Gloria Simov
CEO, President & Director11.5yrsUS$5.00kno data
Heather Sharp
Chief Financial Officer11.3yrsno datano data
Vino Padayachee
Chairman & Business Development Director10.9yrsno datano data

11.3yrs

Average Tenure

52yo

Average Age

Experienced Management: LIFS's management team is seasoned and experienced (11.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Gloria Simov
CEO, President & Director11.5yrsUS$5.00kno data
Heather Sharp
Chief Financial Officerno datano datano data
Vino Padayachee
Chairman & Business Development Director10.9yrsno datano data
Roberto Viña
Member of Medical Advisory Board10.8yrsno datano data
Matthew Sullivan
Member of Executive Advisory Board11.3yrsno datano data
David Granovsky
Corporate Advisorno datano datano data
Shahab Bakhtyar
Member of Executive Advisory Board11.3yrsno datano data
Shirin Rostamkalaee
Member of Executive Advisory Board11.3yrsno datano data
Ranbir Gill
Member of Medical Advisory Board10.8yrsno datano data
Praveen Gill
Member of Medical Advisory Board10.8yrsno datano data

11.1yrs

Average Tenure

52yo

Average Age

Experienced Board: LIFS's board of directors are seasoned and experienced ( 11.1 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/11 04:13
End of Day Share Price 2024/12/24 00:00
EarningsN/A
Annual EarningsN/A

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Life Stem Genetics Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.